Melanoma Information Center
Each year in the United States, more than 62,000 people are diagnosed with melanoma. There are an estimated 723,000 melanoma survivors living in the United States today. Exposure to ultraviolet radiation increases the risk of melanoma, and sun protection plays an important role in melanoma prevention. Once melanoma occurs, it is important to detect and treat it as early as possible in order to obtain the best outcomes.
Early-stage melanoma may be treated with surgery alone, but treatment of more advanced disease remains challenging. Researchers are continuing to explore new approaches to treatment in clinical trials. Advances are also being made in supportive care; high-quality supportive care makes melanoma treatment more tolerable and improves quality of life.
Understanding melanoma treatment options, the role of different doctors specializing in the treatment of melanoma, and how and when to access new and innovative melanoma treatment options available through clinical trials is essential in order to achieve the best outcome from melanoma treatment.
The Cancer Consultants Melanoma Information Center has been designed to help patients understand options for melanoma prevention, early detection, and treatment, while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of melanoma.
Headline Melanoma News 
Approximately 16% of Worldwide Cancers Caused By Preventable Infections
About 16% of cancers worldwide are the result of preventable and treatable infections.
Women More Likely to Survive Melanoma Than Men
Women are 30 percent more likely to survive melanoma than men.
Aspirin Continues to Look Promising for Cancer Prevention
Study reports fewer cases and fewer deaths with daily use.
Melanoma Tips
Men, Fertility, and Cancer Men who confront a cancer diagnosis before beginning or completing their families...
Women, Fertility and Cancer Women who confront a cancer diagnosis before beginning or completing their families...
What is Genomics? You’ve probably heard of genetic testing for cancer susceptibility, but the more...
Melanoma Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Melanoma Clinical Trials
VicalLX01-315-02 – A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment with 2 mg Intralesional Allovectin-7 Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects with Recurrent Metastatic Melanoma
COGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN 2b in Stage T3-T4 or N1 (microscopic) Melanoma
ECOGE1697 – Phase III Randomized Study of Four Weeks High Dose IFN-a2b in Stage T2b No, T3a-bNo, T4a-b No, and T1-2, N1a, 2a (microscopic) Melanoma.
 |
 |
 |
 |
